All
I Didn’t Think I Would Be Strong Enough to Survive Cancer 20 Years Ago, But I Was so Wrong
February 1st 2022A woman with metastatic breast cancer reflects on her pre-cancer life 20 years ago and how her perspective on the disease has shifted as she’s reached a level of acceptance and hope for the future.
A Tireless Champion for Change in the Metastatic Breast Cancer Field
February 1st 2022A colleague describes how a woman who was diagnosed with breast cancer that later metastasized felt a lack of support and research, leading her to launch support programs for other patients and step into the advocacy field.
Healthy Diet and Lifestyle May Improve Survival Rates for Patients With Stage 3 Colon Cancer
January 31st 2022Patients with stage 3 colon cancer should feel empowered to start a healthy lifestyle and diet, says a researcher, after recent study results demonstrated positive survival and recurrence outcomes.
Torn Between Looking ‘Normal’ and Being Myself: A Cancer Survivor’s Newfound Breast Envy
January 31st 2022A breast cancer survivor describes how preparing an outfit for her son’s upcoming wedding and seeing social media photos of other women sparked body envy within her for those who have not been affected by breast cancer surgeries.
When COVID-19 Cancels Your Cancer Appointments: Why Are We Still in Crisis Mode 2 Years Later?
January 29th 2022A colon cancer survivor expresses her frustration about the way the health care system is currently being managed as yet another wave of COVID-19 cases caused her to cancel an appointment she’d waited three months for.
Skin-Related Side Effects From a Certain Cancer Treatment May Indicate Stronger Responses, Survival
January 28th 2022Side effects from cancer treatment with immunotherapy, which may include vitiligo and certain rashes, may point to who will respond better to the treatment, although more research is needed to determine how much weight to put on these data.
New Drug Combination May Improve Outcomes in Unresectable Liver Cancer
January 27th 2022An expert from Memorial Sloan Kettering Cancer Center in New York discusses the promising findings from a study that analyzed tremelimumab plus Imfinzi for unresectable hepatocellular carcinoma, and outlines side effects patients should discuss with their doctor.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.